NCT07002853 Nature-based Intervention for Chronic Pain in Older People
| NCT ID | NCT07002853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université du Québec à Chicoutimi |
| Condition | Chronic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-05-22 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-05-22 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a nature-based intervention program has positive effects on the physical and psychosocial health in a group of older participants with chronic non-specific lower back pain. The main questions it aims to answer are: Will the program improve: * The physical outcomes such as mobility, strength and balance? * The psychosocial health outcomes? Participants will: * Be assessed before and after the program; * Participate in one session per week of the intervention.
Eligibility Criteria
Inclusion Criteria: * Aged 65 years + * Having low back pain for 3 months or more * Being able to walk independently * Mental state \>25/30 in the MMSE questionnaire * Frailty score \<3/5 (Fried criterias) Exclusion Criteria: * Presenting other severe musculoskeletal, cardiovascular, or neurological conditions, or systemic diseases (e.g., cancer).
Contact & Investigator
Rubens A. da Silva, Ph.D.
STUDY DIRECTOR
Université du Québec à Chicoutimi
Frequently Asked Questions
Who can join the NCT07002853 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07002853 currently recruiting?
Yes, NCT07002853 is actively recruiting participants. Contact the research team at rubens.dasilva@uqac.ca for enrollment information.
Where is the NCT07002853 trial being conducted?
This trial is being conducted at Saguenay, Canada.
Who is sponsoring the NCT07002853 clinical trial?
NCT07002853 is sponsored by Université du Québec à Chicoutimi. The principal investigator is Rubens A. da Silva, Ph.D. at Université du Québec à Chicoutimi. The trial plans to enroll 15 participants.